This previously uncharacterized interplay between glycosylation and ubiquitylation highlights how obesity‐induced metabolic reprogramming via the hexosamine biosynthetic pathway (HBP) amplifies YAP activity and stability. The gene discussed is YAP1; the disease is obesity disorder.